AMPLEXD THERAPEUTICS TO REVOLUTIONISE HPV-INDUCED CERVICAL PRECANCER TREATMENTS
KUALA LUMPUR, Amplexd Therapeutics Inc (Amplexd) has secured US$2 million from an Asia-based life sciences focused family office, towards the finalisation of product development ahead of Phase 1/2 clinical trials for its non-invasive treatments of Ce…